CLINICAL_TRIALS
trial_result
· 2020-06-26
Clinical Trial Update: Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat [Phase 1]
Summary
Phase 1 pharmacokinetics and metabolism study of radiolabelled linerixibat in cholestasis patients; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Cholestasis | Phase 1 | Status: COMPLETED | Results posted: 2020-06-26